Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Kidney Neoplasms 1Head and Neck Neoplasms 1Breast Screening 1Advanced Malignant Neoplasm 1

Interventions

Cisplatin 41Radiotherapy 32Fluorouracil 14Paclitaxel 13Docetaxel 12Cetuximab 12Radiotherapy, Intensity-Modulated 9Carboplatin 8Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 4Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Chemotherapy, Adjuvant 3vandetanib 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiosurgery 2Pilocarpine 2Panitumumab 2Neoadjuvant Therapy 2Lapatinib 2Isotretinoin 2In Situ Hybridization 2Fluorodeoxyglucose F18 2Filgrastim 2Epoetin Alfa 2Drug Therapy 2Biopsy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Head and Neck Neoplasms × Genetic Testing × Clear all
NCT00646659 2018-07-09

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡